Henry Ford Health and Ascension Michigan have signed an agreement to enter a joint venture that will bring together Ascension’s southeast Michigan and Genesys h
Monoclonal antibodies can cut risk of hospitalization, death by 70% in COVID-19 patients
Western Michigan University Homer Stryker M.D. School of Medicine
A West Michigan doctor said monoclonal antibody therapy can cut the risk of hospitalization and death by around 70% if given early enough after testing positive for COVID-19.
and last updated 2021-04-14 18:41:18-04
KALAMAZOO, Mich. â A COVID-19 antibody treatment is being expanded throughout Michigan, which was
A West Michigan doctor said it can cut the risk of hospitalization and death by around 70% if given early enough after testing positive.
Since emergency approval by the FDA last November, over 5,600 Michiganders have been treated with monoclonal antibodies, which are copies of antibodies or immune system proteins that seek out the virus.